HOXB2
Basic information
Region (hg38): 17:48540894-48545109
Previous symbols: [ "HOX2", "HOX2H" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HOXB2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 27 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 0 | 0 |
Variants in HOXB2
This is a list of pathogenic ClinVar variants found in the HOXB2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-48543130-A-G | not specified | Uncertain significance (Dec 16, 2023) | ||
17-48543213-A-T | not specified | Uncertain significance (Oct 03, 2022) | ||
17-48543214-A-T | not specified | Uncertain significance (Oct 03, 2022) | ||
17-48543231-A-G | not specified | Uncertain significance (Mar 07, 2023) | ||
17-48543241-C-A | not specified | Uncertain significance (Jan 18, 2023) | ||
17-48543262-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
17-48543263-T-G | not specified | Uncertain significance (Nov 09, 2022) | ||
17-48543274-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
17-48543292-C-A | not specified | Uncertain significance (Apr 25, 2022) | ||
17-48543322-A-C | not specified | Uncertain significance (Nov 15, 2021) | ||
17-48543342-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
17-48543346-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
17-48543361-G-T | not specified | Uncertain significance (Jan 26, 2023) | ||
17-48543445-G-C | not specified | Uncertain significance (Sep 25, 2023) | ||
17-48543457-G-C | not specified | Uncertain significance (Apr 22, 2022) | ||
17-48543490-C-G | not specified | Uncertain significance (Aug 01, 2022) | ||
17-48543525-C-T | not specified | Uncertain significance (Jul 12, 2022) | ||
17-48543526-G-C | not specified | Uncertain significance (Aug 14, 2023) | ||
17-48543540-C-G | not specified | Uncertain significance (Jul 06, 2021) | ||
17-48544547-G-A | not specified | Uncertain significance (Sep 23, 2023) | ||
17-48544577-G-A | not specified | Uncertain significance (May 04, 2022) | ||
17-48544637-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
17-48544649-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
17-48544691-T-G | not specified | Uncertain significance (Oct 26, 2022) | ||
17-48544731-A-G | not specified | Uncertain significance (Apr 26, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HOXB2 | protein_coding | protein_coding | ENST00000330070 | 2 | 5186 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000146 | 0.674 | 125689 | 0 | 59 | 125748 | 0.000235 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.57 | 270 | 206 | 1.31 | 0.00000940 | 2249 |
Missense in Polyphen | 84 | 74.181 | 1.1324 | 878 | ||
Synonymous | -0.686 | 107 | 98.4 | 1.09 | 0.00000472 | 793 |
Loss of Function | 0.844 | 7 | 9.86 | 0.710 | 4.20e-7 | 113 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000248 | 0.000240 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000335 | 0.000326 |
Finnish | 0.000201 | 0.000185 |
European (Non-Finnish) | 0.000230 | 0.000220 |
Middle Eastern | 0.000335 | 0.000326 |
South Asian | 0.000599 | 0.000588 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. {ECO:0000269|PubMed:10595394}.;
- Pathway
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
(Consensus)
Intolerance Scores
- loftool
- 0.292
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 46.92
Haploinsufficiency Scores
- pHI
- 0.382
- hipred
- N
- hipred_score
- 0.178
- ghis
- 0.478
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.861
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hoxb2
- Phenotype
- normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); muscle phenotype; vision/eye phenotype; craniofacial phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- morphogenesis of an epithelial sheet;multicellular organism development;blood circulation;anterior/posterior pattern specification;dorsal/ventral pattern formation;rhombomere 3 development;rhombomere 4 development;facial nerve structural organization;positive regulation of transcription by RNA polymerase II;embryonic skeletal system morphogenesis;neural nucleus development
- Cellular component
- nucleus;nucleoplasm;cytosol;nuclear speck
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;sequence-specific DNA binding